[1]
|
Duman, R.S. and Monteggia, L.M. (2006) A Neurotrophic Model for Stress-Related Mood Disorders. Biological Psychiatry, 59, 1116-1127. https://doi.org/10.1016/j.biopsych.2006.02.013
|
[2]
|
Kessler, R.C., Berglund, P., Demler, O., et al. (2005) Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication. BMC Complementary & Alternative Medicine, 14, 593-602. https://doi.org/10.1001/archpsyc.62.6.593
|
[3]
|
Tyrer, P. (2001) The Case for Cothymia: Mixed Anxiety and Depression as a Single Diagnosis. British Journal of Psychiatry, 179, 191-193. https://doi.org/10.1192/bjp.179.3.191
|
[4]
|
Ferrari, A.J., Charlson, F.J., Norman, R.E., et al. (2013) Burden of Depressive Disorders by Country, Sex, Age, and Year: Findings from the Global Burden of Disease Study 2010. PLoS Medicine, 10, Article ID: 1001547. https://doi.org/10.1371/journal.pmed.1001547
|
[5]
|
Xia, W., Zhao, H., Ren, A.H., et al. (2005) BDNF Gene Expression in the Habenular Nucleus and Hippocampus of Experimental Depressed Rats. Chinese Journal of Immunity Journal of Science, 21, 277-278.
|
[6]
|
Castrn, E., Voikar, V. and Rantamki, T. (2007) Role of Neurotrophic Factors in Depression. Current Opinion in Pharmacology, 7, 18-21. https://doi.org/10.1016/j.coph.2006.08.009
|
[7]
|
Robakis, T.K. and Williams, K.E. (2013) Biologically Based Treatment Approaches to the Patient with Resistant Perinatal Depression. Archives of Women’s Mental Health, 16, 343-351. https://doi.org/10.1007/s00737-013-0366-7
|
[8]
|
Simon, S.R. (1999) Moses Maimonides: Medieval Physician and Scholar. Archives of Internal Medicine, 159, 1841-1845. https://doi.org/10.1001/archinte.159.16.1841
|
[9]
|
Pignone, M.P., Gaynes, B.N., Rushton, J.L., et al. (2002) Screening for Depression in Adults: A Summary of the Evidence for the U.S. Preventive Services Task Force. Archives of Internal Medicine, 136, 765-776. https://doi.org/10.7326/0003-4819-136-10-200205210-00013
|
[10]
|
Barde, Y.A., Edgar, D. and Thoenen, H. (1982) Purification of a New Neurotrophic Factor from Mammalian Brain. EMBO Journal, 1, 549-553. https://doi.org/10.1002/j.1460-2075.1982.tb01207.x
|
[11]
|
Karege, F., Perret, G., Bondolfi, G., et al. (2002) Decreased Serum Brain-Derived Neurotrophic Factor Levels in Major Depressed Patients. Psychiatry Research, 109, 143-148. https://doi.org/10.1016/S0165-1781(02)00005-7
|
[12]
|
Kim, Y.K., Lee, H.P., Won, S.D., et al. (2007) Low Plasma BDNF Is Associated with Suicidal Behavior in Major Depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 31, 78-85. https://doi.org/10.1016/j.pnpbp.2006.06.024
|
[13]
|
Haghighi, M., Salehi, I., Erfani, P., Jahangard, L, et al. (2013) Additional ECT Increases BDNF-Levels in Patients Suffering from Major Depressive Disorders Compared to Patients Treated with Citalopram Only. Journal of Psychiatric Research, 47, 908-915. https://doi.org/10.1016/j.jpsychires.2013.03.006
|
[14]
|
Yoshimura, R., Ikenouchi-Sugita, A., Hori, H., et al. (2010) Adding a Low Dose Atypical Antipsychotic Drug to an Antidepressant Induced a Rapid Increase of Plasma Brain-Derived Neurotrophic Factor Levels in Patients with Treatment-Resistant Depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 34, 308-312. https://doi.org/10.1016/j.pnpbp.2009.12.003
|
[15]
|
Birkenhager, T.K., Geldermans, S., Van den Broek, W.W., et al. (2012) Serum Brain-Derived Neurotrophic Factor Level in Relation to Illness Severity and Episode Duration in Patients with Major Depression. Journal of Psychiatric Research, 46, 285-289. https://doi.org/10.1016/j.jpsychires.2011.12.006
|
[16]
|
Larsen, M.H., Mikkelsen, J.D., Hay-Schmidt, A., et al. (2010) Regulation of Brain-Derived Neurotrophic Factor (BDNF) in the Chronic Unpredictable Stress Rat Model and the Effects of Chronic Antidepressant Treatment. Journal of Psychiatric Research, 44, 808-816. https://doi.org/10.1016/j.jpsychires.2010.01.005
|
[17]
|
Zhang, Y., Gu, F., Chen, J., et al. (2010) Chronic Antidepressant Administration Alleviates Frontal and Hippocampal BDNF Deficits in CUMS Rat. Brain Research, 1366, 141-148. https://doi.org/10.1016/j.brainres.2010.09.095
|
[18]
|
Nibuya, M., Morinobu, S. and Duman, R.S. (1995) Regulation of BDNF and trkB mRNA in Rat Brain by Chronic Electroconvulsive Seizure and Antidepressant Drug Treatments. The Journal of Neuroscience, 15, 7539-7547. https://doi.org/10.1523/JNEUROSCI.15-11-07539.1995
|
[19]
|
Malberg, J.E., Eisch, A.J., Nestler, E.J., et al. (2000) Chronic Antidepressant Treatment Increases Neurogenesis in Adult Rat Hippocampus. The Journal of Neuroscience, 20, 9104-9110. https://doi.org/10.1523/JNEUROSCI.20-24-09104.2000
|
[20]
|
Hoshaw, B.A., Malberg, J.E. and Lucki, I. (2005) Central Administration of IGF-I and BDNF Leads to Long-Lasting Antidepressant-Like Effects. Brain Research, 1037, 204-208. https://doi.org/10.1016/j.brainres.2005.01.007
|
[21]
|
Schmidt, H.D. and Duman, R.S. (2010) Peripheral BDNF Produces Antidepressant-Like Effects in Cellular and Behavioral Models. Neuropsychopharmacology, 35, 2378-2391. https://doi.org/10.1038/npp.2010.114
|
[22]
|
Watanabe, K., Hashimoto, E., Ukai, W., et al. (2010) Effect of Antidepressants on Brain-Derived Neurotrophic Factor (BDNF) Release from Platelets in the Rats. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 34, 1450-1454. https://doi.org/10.1016/j.pnpbp.2010.07.036
|
[23]
|
Li, T.S., Jiang, L., Chen, H.S., et al. (2008) Brain-Derived Neurotrophic Factor Promotes the Survival of Hippocampal Neural Stem Cells, Proliferation and Differentiation into Neurons. Chinese Journal of Cell Biology, No. 3, 387-391.
|
[24]
|
Scharfman, H., Goodman, J., Macleod, A., et al. (2005) Increased Neurogenesis and the Ectopic Granule Cells after Intrahippocampal BDNF Infusion in Adult Rats. Exp Neurol, 192, 348-356. https://doi.org/10.1016/j.expneurol.2004.11.016
|
[25]
|
Vidal, R., Pilar-Cuellar, F., Dos, A.S., et al. (2011) Rodriguez-Gaztelumendi A, Mostany R, Castro E, Diaz A, Valdizan EM, Pazos A: New Strategies in the Development of Antidepressants: Towards the Modulation of Neuroplasticity Pathways. Current Pharmaceutical Design, 17, 521-533. https://doi.org/10.2174/138161211795164086
|
[26]
|
Karege, F., Perret, G., Bondolfi, G., et al. (2002) Decreased Serum Brain-Derived Neurotrophic Factor Levels in Major Depressed Patients. Psychiatry Research, 109, 143-148. https://doi.org/10.1016/S0165-1781(02)00005-7
|
[27]
|
Duman, R.S. (2004) Role of Neurotrophic Factors in the Etiology and Treatment of Mood Disorders. Neuromolecular Medicine, 5, 11-25. https://doi.org/10.1385/NMM:5:1:011
|
[28]
|
Li, Y., Luikart, B.W., Birnbaum, S., et al. (2008) TrkB Regulates Hippocampal Neurogenesis and Governs Sensitivity to Antidepressive Treatment. Neuron, 59, 399-412. https://doi.org/10.1016/j.neuron.2008.06.023
|
[29]
|
Numakawa, T., Yamagishi, S., Adachi, N., et al. (2002) Brain-Derived Neurotrophic Factor-Induced Potentiation of Ca(2+) Oscillations in Developing Cortical Neurons. Journal of Biological Chemistry, 277, 6520-6529. https://doi.org/10.1074/jbc.M109139200
|
[30]
|
Peng, C.H., Chiou, S.H., Chen, S.J., et al. (2008) Neuroprotection by Imipramine against Lipopolysaccharide-Induced Apoptosis in Hippocampus-Derived Neural Stem Cells Mediated by Activation of BDNF and the MAPK Pathway. European Neuropsychopharmacology, 18, 128-140. https://doi.org/10.1016/j.euroneuro.2007.05.002
|
[31]
|
Shi, S.S. and Ning, X.X. (2007) Expression of BDNF and TrkB in Rat Cerebellum. Journal of Practical Medical Technology, 14, 1110-1113.
|
[32]
|
Egan, M.F., Kojima, M., Callicott, J.H., et al. (2003) The BDNF Val66Met Polymorphism Affects Activity-Dependent Secretion of BDNF and Human Memory and Hippocampal Function. Cell, 112, 257-269. https://doi.org/10.1016/S0092-8674(03)00035-7
|
[33]
|
Yuan, Q., Wu, W., So, K.F., et al. (2000) Effects of Neurotrophic Factors on Motoneuron Survival Following Axonal Injury in Newborn Rats. Neuroreport, 11, 2237-2241. https://doi.org/10.1097/00001756-200007140-00035
|
[34]
|
Gorski, J.A., Zeiler, S.R., Tamowski, S., et al. (2003) Brain Derived Neurotrophic Factor Is Required for the Maintenance of Cortical Dendrites. Journal of Neuroscience, 23, 6856-6865. https://doi.org/10.1523/JNEUROSCI.23-17-06856.2003
|
[35]
|
Glass, D.J. and Yancopoulos, G.D. (1993) The Neurotrophins and Their Receptors. Trends in Cell Biology, 3, 262-279. https://doi.org/10.1016/0962-8924(93)90054-5
|
[36]
|
Blanquet, P.R. and Lamour, Y. (1997) Brain-Derived Neurotrophic Factor Increases Ca2+/Calmodulin Dependent Protein Kinase Activity in Hippocampus. Journal of Biological Chemistry, 270, 24133-24136. https://doi.org/10.1074/jbc.272.39.24133
|
[37]
|
Tsankova, N.M., Berton, O., Renthal, W., et al. (2006) Sustained Hippocampal Chromatin Regulation in a Mouse Model of Depression and Antidepressant Action. Nature Neuroscience, 9, 519-525. https://doi.org/10.1038/nn1659
|
[38]
|
Rasmusson, A.M., Shi, L. and Duman, R. (2002) Downregulation of BDNF and mRNF and mRNA in the Hippocampal Dentate Gyrus after Re-Exposure to Cues Previously Associated with Footshock. Neuropsycho Pharmacology, 27, 133-142. https://doi.org/10.1016/S0893-133X(02)00286-5
|
[39]
|
Yin, L.H., Li, X.C., Lu, L., et al. (2009) Cerebral Spinal Fluid, Hippocampal and Cortical Tissue of Depressed Rats Were Involved in Brain-Derived Psychic Management Changes of Nutrient Factors in Rats. Journal of Third Military Medical University, 31, 230-232.
|
[40]
|
Mervaala, E., Fohr, J., Kononen, M., et al. (2000) Quantitative MR I of the Hippocampus and Amygdala in Severe Depression. Psychological Medicine, 30, 117-125. https://doi.org/10.1017/S0033291799001567
|
[41]
|
Karege, F., Vaudan, G., Schwald, M., et al. (2005) Neurotrophin Levels in Postmortem Brains of Suicide Victims and the Effects of Antemortem Diagnosis and Psychotropic Drags. Brain Research. Molecular Brain Research, 136, 29-37. https://doi.org/10.1016/j.molbrainres.2004.12.020
|
[42]
|
Gonul, A.S., Akdeniz, F., Taneli, F., et al. (2005) Effect of Treatment on Serum Brain-Derived Neurotrophic Factor Levels in Depressed Patients. European Archives of Psychiatry and Clinical Neuroscience, 255, 381-386. https://doi.org/10.1007/s00406-005-0578-6
|
[43]
|
Chen, Z.Y., Jing, D., Bath, K.G., et al. (2006) Genetic Variant BDNF (Va166Met) Polymorphism Alters Anxiety-Related Behavior. Science, 314, 140-143. https://doi.org/10.1126/science.1129663
|
[44]
|
Sen, S., Nesse, R.M., Stoltenberg, S.F., et al. (2003) A BDNF Coding Variant Is Associated with the NEO Personality Inventory Domain Neuroticism, a Risk Factor for Depression. Neuropsychopharmacology, 28, 397-401. https://doi.org/10.1038/sj.npp.1300053
|
[45]
|
Lang, U.E., Hellweg, R., Kalus, P., et al. (2005) Association of a Functional BDNF Polymorphism and Anxietyrelated Personality Traits. Psychopharmacology (Berl), 180, 95-99. https://doi.org/10.1007/s00213-004-2137-7
|
[46]
|
Schüle, C., Zill, P., Baghai, T.C., et al. (2006) Brain Derived Neurotrophic Factor Val66Met Polymorphism and Dexamethasone/CRH Test Results in Depressed Patients. Psychoneuroendocrinology, 31, 10-19. https://doi.org/10.1016/j.psyneuen.2006.06.002
|
[47]
|
Hwang, J.-P., Tsai, S.-J., Hong, C.-J., et al. (2006) The Val66Met Polymorphism of the Brain Derived Neurotrophic Factor Gene Is Associated with Geriatric Depression. Neurobiology of Aging, 27, 18-34. https://doi.org/10.1016/j.neurobiolaging.2005.10.013
|
[48]
|
Gonul, A.S., Akdeniz, F., Taneli, F., et al. (2005) Effect of Treatment on Serum Brain-Derived Neurotrophic Factor Levels in Depressed Patients. European Archives of Psychiatry and Clinical Neuroscience, 255, 381-386. https://doi.org/10.1007/s00406-005-0578-6
|
[49]
|
Suttees, P.G., Wainwright, N.W., Willis-Owen, S.A., et al. (2007) No Association between the BDNF Va166Met Polymorphism and Mood Status in a Non-Clinical Community Sample of 7389 Older Adults. Journal of Psychiatric Research, 41, 404-409. https://doi.org/10.1016/j.jpsychires.2006.01.004
|
[50]
|
Croll, S.D., Nancy, Y., Ronald, M., et al. (1998) Expression of BDNF and trkB as a Function of Age and Cognitive Performance. Brain Research, 812, 200-218. https://doi.org/10.1016/S0006-8993(98)00993-7
|